| abstract |
The present invention relates to a glucomannan with a molecular size of 730 kDa, called DOP, which was previously identified as the unique authentication marker of the expensive herb Dendrobium officinals , as the main component for combating fatigue in subjects in need thereof. In particular, the present invention provides the required dosage for DOP to provide a potent anti-fatigue effect, stronger than Rhodiola rosea extract, and has significant potential to form an anti-fatigue health product. |